Contemporary Surgical Management of Atrial Fibrillation

Tyler M Gunn1, Tessa E London1, Sibu P Saha1

  • 1Division of Cardiothoracic Surgery, University of Kentucky, Lexington, Kentucky.

Insights

Atrial fibrillation (AF) treatments have advanced significantly. This review covers surgical and catheter-based procedures for managing this common heart rhythm disorder and its associated risks.

Area of Science:

  • Cardiology
  • Cardiac Electrophysiology
  • Medical Technology

Background:

  • Atrial fibrillation is a prevalent arrhythmia impacting quality of life.
  • It elevates risks of stroke, heart failure, and sudden cardiac death.
  • Recent decades have seen major advancements in AF treatment modalities.

Purpose of the Study:

  • To review current indications for AF treatment.
  • To summarize available surgical and catheter-based treatment options.
  • To discuss outcomes, techniques, and technical progress in AF management.

Main Methods:

  • Comprehensive literature review.
  • Analysis of published data on atrial fibrillation interventions.
  • Synthesis of information on surgical and catheter ablation techniques.

Main Results:

  • Multiple surgical and catheter-based procedures exist for atrial fibrillation.
  • These interventions aim to restore normal heart rhythm and reduce complications.
  • Outcomes and technical refinements continue to evolve.

Conclusions:

  • Effective treatment options are available for atrial fibrillation.
  • Ongoing research and technological innovation are improving patient outcomes.
  • Management strategies are tailored to individual patient needs and risk profiles.

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
305
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
169
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
267
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
205
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
194
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
159